STOCK TITAN

Lazard, Inc. SEC Filings

LAZ NYSE

Welcome to our dedicated page for Lazard SEC filings (Ticker: LAZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Lazard's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Lazard's regulatory disclosures and financial reporting.

Rhea-AI Summary

Lazard, Inc. is soliciting shareholder votes at its 2026 Annual Meeting on May 21, 2026, on five proposals: election of three directors, an advisory vote on executive compensation, amendment to declassify the Board over three years, an amendment to increase the 2018 Incentive Compensation Plan reserve by 25 million shares, and ratification of Deloitte as auditor.

2025 highlights shown in the proxy include GAAP net revenue of $3,099 million, adjusted net revenue of $3,030 million, ending AUM of $254 billion, and reported return of capital comprising $187 million in dividends and $91 million of repurchases. CEO Peter Orszag’s 2025 compensation totaled $15 million, with performance-based awards representing approximately 94% of his pay.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Lazard, Inc. executive Christopher Hogbin reported compensation-related equity activity and follow-on share sales. On vesting of prior Restricted Stock Unit (RSU) awards, he acquired 48,332 shares of Common Stock at no cost. The company withheld 24,674 shares to cover tax obligations tied to this vesting.

He then executed open-market sales of 7,885 shares at $40.37 on March 18 and 3,944 shares at $39.37 on March 19 under a pre-arranged Rule 10b5-1 trading plan intended to cover estimated taxes and personal expenditures. Following these transactions, he holds 11,829 Common shares directly and 260,989 RSUs, indicating he retains a substantial equity interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

LAZ reported transactions in restricted and open-market common stock. The filing lists 3,944 shares tied to restricted stock vesting on 03/17/2026 and shows 7,885 shares sold on 03/18/2026 by Christopher Hogbin. The transactions are reported on Form 144 and relate to compensation vesting and a subsequent sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

LAZ filed a Form 144 reporting insider sales. Reported sales by Mary A. Betsch total $557,273.08 in proceeds from two transactions: $496,112.53 for 12,121 shares sold on 03/17/2026 and $61,160.55 for 1,515 shares sold on 03/18/2026. The filing also lists Restricted Stock Vesting on 03/16/2026 for 1,515 shares described as compensation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Farr Tracy reported acquisition or exercise transactions in this Form 4 filing.

Lazard, Inc. Chief Financial Officer Tracy Farr received a grant of 12,982 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock. After this award, Farr holds 37,576 shares-equivalent RSUs directly.

The RSUs vest over three years, with 4,327 units scheduled to vest on or around March 1, 2027, another 4,327 on or around March 1, 2028, and 4,328 on or around March 1, 2029. This is a compensation-related equity award rather than an open-market stock purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Lazard, Inc. CEO and Chairman Peter Richard Orszag reported a combination of equity awards and share sales. On March 16, 2026, he exercised 138,340 Restricted Participation Units, receiving the same number of Lazard common shares at a conversion price of $0.00 per unit.

To cover estimated taxes from this exchange, he disposed of 41,502 shares to the company at an average price of $40.82 per share. On March 17, 2026, he conducted open-market sales totaling 69,170 shares at weighted-average prices of $40.7318 and $41.6593 per share, executed under a pre-arranged Rule 10b5-1 trading plan intended to cover estimated taxes and personal expenditures. Following these transactions, he directly owns 210,942 shares of Lazard common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Soto Alexandra reported acquisition or exercise transactions in this Form 4 filing.

Lazard, Inc. Chief Operating Officer Alexandra Soto received a grant of 101,739 Restricted Stock Units, each representing a right to one share of common stock. These RSUs are scheduled to vest on or around March 1, 2029. Following this award, she holds 301,483 shares and units directly, underscoring that this filing reflects compensation rather than an open-market trade.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Gathy Michael reported acquisition or exercise transactions in this Form 4 filing.

Lazard, Inc. reported that Chief Accounting Officer Michael Gathy received a grant of 5,564 Restricted Stock Units, each representing one share of common stock. This award increases his directly held RSUs to 12,758. Portions of the grant are scheduled to vest in March 2027, March 2028, and March 2029.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

LAZ filed a Section 144 notice reporting a proposed sale of 1,515 shares of Common Stock associated with restricted stock vesting on 03/16/2026. The filing also discloses a sale of 12,121 shares on 03/17/2026 for $496,112.53.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Lazard (LAZ) SEC filings are available on StockTitan?

StockTitan tracks 100 SEC filings for Lazard (LAZ), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Lazard (LAZ)?

The most recent SEC filing for Lazard (LAZ) was filed on March 23, 2026.